Literature DB >> 32165218

Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies.

Agnieszka Potasiewicz1, Malgorzata Holuj2, Ewa Litwa2, Kinga Gzielo2, Lucyna Socha2, Piotr Popik2, Agnieszka Nikiforuk2.   

Abstract

Social dysfunction is among the core symptoms of schizophrenia. The neuropeptides oxytocin (OXT) and vasopressin (VP) are involved in the regulation of social behaviour and social cognition. There are indications that both of these neurotransmitter systems are altered in schizophrenia. Prenatal (embryonic day 17) exposure to the neurotoxin methylazoxymethanol acetate (MAM; 22 mg/kg) leads to a schizophrenia-like phenotype in rats and has been used as a model of schizophrenia symptoms. Here, we examined the social phenotype of MAM-exposed female and male rats and measured concentrations of OXT, VP and their specific receptors in various brain areas involved in the control of social behaviour. We report decreases in social behaviour and ultrasonic vocalisations (USVs) in the MAM rats during social encounters. Specifically, the duration of social interactions and number of corresponding USVs were reduced in this group. In the MAM rats, "positive" 50-kHz USVs were flatter, i.e., displayed lower bandwidth, a greater percentage of "short" calls and lower percentage of frequency-modulated calls. The MAM animals exhibited diminished interest towards social stimuli in olfactory preference tests. In the resident-intruder test, MAM exposure reduced dominance behaviour only in the males. We also report cognitive impairments, including reduced novel object recognition and cognitive inflexibility in the attentional set shifting test, and decreased OXT and OXT receptor concentrations in the prefrontal cortex and hypothalamus and VP and VP receptors in the hypothalamus in the MAM rats. Deficits in central OXT and VP systems may underlie abnormalities present in the MAM model of schizophrenia.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  ASST; Methylazoxymethanol; NORT; Negative symptoms; Schizophrenia; USV

Mesh:

Substances:

Year:  2020        PMID: 32165218     DOI: 10.1016/j.neuropharm.2020.108040

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  3 in total

Review 1.  Multiple Aspects of Inappropriate Action of Renin-Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases.

Authors:  Ewa Szczepanska-Sadowska; Agnieszka Wsol; Agnieszka Cudnoch-Jedrzejewska; Katarzyna Czarzasta; Tymoteusz Żera
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

2.  The Antioxidant N-Acetyl-L-Cysteine Restores the Behavioral Deficits in a Neurodevelopmental Model of Schizophrenia Through a Mechanism That Involves Nitric Oxide.

Authors:  Ana Lopes-Rocha; Thiago Ohno Bezerra; Roberta Zanotto; Inda Lages Nascimento; Angela Rodrigues; Cristiane Salum
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

3.  Adult stress exposure blunts dopamine system hyperresponsivity in a neurodevelopmental rodent model of schizophrenia.

Authors:  Millie Rincón-Cortés; Anthony A Grace
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.